GlassScriptPhysician profile
Jennifer Camp
NPI 1760086557
$6,230.01
in general payments reported to CMS, 2019-2025
25 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,988 · 2022: $3,024 · 2023: $958 · 2024: $154 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $917.03 | 2021-2023 | Trelegy Ellipta, Nucala |
| Jazz Pharmaceuticals INC. | $797.34 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $632.35 | 2021-2023 | Ofev |
| Mallinckrodt Hospital Products INC. | $631.00 | 2021-2022 | |
| Insmed, INC. | $469.07 | 2021-2023 | Arikayce |
| Grifols USA, LLC | $457.54 | 2021-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $399.26 | 2021-2023 | Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $297.47 | 2021-2023 | Dupixent |
| Harmony Biosciences LLC | $276.50 | 2022-2023 | Wakix |
| Boston Scientific Corporation | $210.22 | 2024-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Takeda Pharmaceuticals U.S.A., INC. | $208.18 | 2022-2023 | Glassia |
| Axsome Therapeutics, INC. | $184.23 | 2023-2025 | Sunosi |
| Mylan Specialty L.P. | $175.96 | 2021-2023 | Yupelri |
| Genzyme Corporation | $122.55 | 2022 | |
| Merck Sharp & Dohme LLC | $94.79 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $83.46 | 2022 | |
| Gilead Sciences, INC. | $66.49 | 2021 | |
| Idorsia Pharmaceuticals US INC | $54.54 | 2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $42.09 | 2022 | |
| Philips North America LLC | $34.28 | 2022-2023 | |
| Inogen, INC. | $19.93 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.17 | 2023 | Edarbi |
| Eisai INC. | $13.33 | 2021 | |
| Corium, LLC | $13.16 | 2023 | Azstarys |
| Sunovion Pharmaceuticals INC. | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Camp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.